JCVI advises up to 12-week COVID-19 vaccine dose interval

AdobeStock_399027595

The JCVI has published a statement on increasing the short-term impact of the vaccination programme, following identification of a new variant of COVID-19 in the UK

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals